Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Post by JLGeminion May 13, 2011 1:53pm
580 Views
Post# 18573483

Welcome Potential Investors - Hold & Buy Oncolytic

Welcome Potential Investors - Hold & Buy Oncolytic

Welcome potential new investors.  The buy side manipulators are still in denial that one retail investor can make a difference.  As of 1:37 PM, ONCY is down 11 cents at $5.65 on a smaller than small volume of 13,600 shares.  The bid is 700 shares at $5.67 with a limited supply side on the ask of 100 shares at $5.69.  On the TSX, trading is close to dead with 3,300 shares traded.

 

My advice is usually to hold and buy but you are new readers.  My advice to you is to buy quickly because the manipulators will not defend their position if they can not see making more money.  I also suspect that they took a short position of 3.8 million shares to drive down the stock price.

Bullboard Posts